What are the current economics?

Historical Growth Track participants received EUR 100,000; current cash, ownership, and partnership terms are unknown.

How large and long is the program?

Five companies selected from 400+ applications across 65+ countries in 2020; no current cohort is published. Historical Growth Track acceleration and Advance Track commercial collaboration.

What happens after the program?

Historical program emphasized direct Bayer collaborations; no current standardized follow-on commitment.

Bayer G4A Digital Health Partnerships (historical global call)

Current standard terms not publicly specified · Global (historical call) · Needs confirmation

Bayer's G4A global digital-health partnership record is historical. The official 2020 announcement documents a Growth Track and Advance Track, but no current global intake, deadline, or universal terms are established.

Tier 3healthcorporate

Official site Open in the live directory

Current application context

Program intake

Needs confirmation

This listing is historical and does not represent a current application cycle.

Checked Aug 10, 2026Authoritative source ↗

Key facts

Terms	Current standard terms not publicly specified
Stage	digital health
Applications	Needs confirmation
Location	Global (historical call)
Remote friendly	No
Warm intro needed	No — open application
Sectors	health, digital-health, pharma
Status	closed

Always confirm on the official page before applying — dates and terms change.

Background

How the application really works

No current global G4A intake was confirmed. Use Bayer's current innovation pages and do not submit through the defunct g4a.health domain.

Tips

Read the cited current official page before applying because program dates and terms are volatile.
State fit with the documented stage, geography, and attendance model; do not rely on an aggregator's old terms.
Ask for the complete investment, fee, and follow-on documents when the public page does not publish them.

Watch out for

Historical Growth Track participants received EUR 100,000; current cash, ownership, and partnership terms are unknown.
The checked global G4A source documents the 2020 cohort; g4a.health no longer resolves and no current global standardized application was found.

Track record

By 2020 Bayer reported supporting 150+ digital-health companies and creating more than 30 direct collaborations.

Historical 2020 selection: 5 from 400+ applications; not a current acceptance rate.

Frequently asked questions

Is this program currently accepting applications?: No current global G4A intake was confirmed. Use Bayer's current innovation pages and do not submit through the defunct g4a.health domain.
What are the current economics?: Historical Growth Track participants received EUR 100,000; current cash, ownership, and partnership terms are unknown.
How large and long is the program?: Five companies selected from 400+ applications across 65+ countries in 2020; no current cohort is published. Historical Growth Track acceleration and Advance Track commercial collaboration.
Can founders participate remotely?: No current policy published.
What happens after the program?: Historical program emphasized direct Bayer collaborations; no current standardized follow-on commitment.

Related accelerators

Founder InstituteWarrant or equity-pool terms vary by agreement · Global Berkeley SkyDeckApproximately 7.5% equity; confirm current fund terms · US Astranova (formerly Newchip)Program terms vary · Global a16z START (historical)Up to $1M (2022 launch terms; not confirmed current) · US (historical)Sequoia Open Source Fellowship0% equity grant support · Global NEA early programsCurrent standard terms not publicly specified · US

Sources

www.bayer.com/media/en-us/bayer-initiates-new-g4a-digital-health-partnerships-program — Official 2020 cohort, funding, application scale, tracks, and historical outcomes (checked 2026-08-10)